These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. El-Missiry A, Elbatrawy A, El Missiry M, Moneim DA, Ali R, Essawy H. J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429 [Abstract] [Full Text] [Related]
23. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. Anderson KH, Ford S, Robson D, Cassis J, Rodrigues C, Gray R. Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608 [Abstract] [Full Text] [Related]
24. Novelty seeking and medication adherence in patients with schizophrenia. Aukst Margetić B, Jakovljević M, Ivanec D, Tošić G, Margetić B. Psychiatry Res; 2011 Mar 30; 186(1):141-3. PubMed ID: 20630601 [Abstract] [Full Text] [Related]
25. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM. J Clin Psychiatry; 2009 Oct 30; 70(10):1397-406. PubMed ID: 19906343 [Abstract] [Full Text] [Related]
26. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia. Rungruangsiripan M, Sitthimongkol Y, Maneesriwongul W, Talley S, Vorapongsathorn T. Arch Psychiatr Nurs; 2011 Aug 30; 25(4):269-83. PubMed ID: 21784285 [Abstract] [Full Text] [Related]
27. Why do patients with schizophrenia who have poor insight still take antipsychotics? Memory deficits as moderators between adherence belief and behavior. Staring AB, van der Gaag M, Duivenvoorden HJ, Weiden PJ, Mulder CL. J Psychiatr Pract; 2011 Sep 30; 17(5):320-9. PubMed ID: 21926527 [Abstract] [Full Text] [Related]
28. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Beck EM, Cavelti M, Kvrgic S, Kleim B, Vauth R. Schizophr Res; 2011 Oct 30; 132(1):42-9. PubMed ID: 21820875 [Abstract] [Full Text] [Related]
34. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia. Lam JW, Lui SS, Wang Y, Chan RC, Cheung EF. Schizophr Res; 2013 Jul 30; 147(2-3):293-300. PubMed ID: 23631929 [Abstract] [Full Text] [Related]
35. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C. Arch Gen Psychiatry; 2005 Jul 30; 62(7):717-24. PubMed ID: 15997012 [Abstract] [Full Text] [Related]
38. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I, Ravanić D, Popović V, Vladejić S, Stanojević A, Stojanović M. Psychiatr Danub; 2011 Dec 30; 23(4):384-8. PubMed ID: 22075740 [Abstract] [Full Text] [Related]